Temperature reduction in cultures of hGM-CSF-expressing CHO cells:: Effect on productivity and product quality

被引:86
作者
Bollati-Fogolín, M
Forno, G
Nimtz, M
Conradt, HS
Etcheverrigaray, M
Kratje, R
机构
[1] Univ Nacl Litoral, Lab Cultivos Celulares, Fac Bioquim & Ciencias Biol, Santa Fe, Argentina
[2] GBF, German Res Ctr Biotechnol, Sturct Biol & Prot Glycosylat, D-38124 Braunschweig, Germany
关键词
D O I
10.1021/bp049825t
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We have demonstrated that temperature reduction from 37 to 33degreesC in the culture of a CHO cell line producing recombinant human granulocyte macrophage colony stimulating factor (CHO-Kl-hGM-CSF) leads to a reduced growth rate, increased cell viability, improved cellular productivity, and decreased cell metabolism. In the present study, CHO-Kl-hGM-CSF cells were cultured in a hiphasic mode: first, a 37degreesC growth phase for achieving a high cell number, followed by a production phase where the culture temperature was shifted to 33degreesC. The maximum cell density was not affected after temperature reduction while cell viability remained above 80% for a further 3.7 days in the culture kept at the lower temperature, when compared to the control culture maintained at 37degreesC. Furthermore, the total rhGM-CSF production increased 6 times in the culture shifted to 33degreesC. Because the quality and hence the in vivo efficacy of a recombinant protein might be affected by numerous factors, we have analyzed the N- and O-glycosylation of the protein produced under both cell culture conditions using high-pH anion-exchange chromatography and complementary mass spectrometry techniques. The product quality data obtained from the purified protein preparations indicated that decreasing temperature had no significant effect on the rhGM-CSF glycosylation profiles, including the degree of terminal sialylation. Moreover, both preparations exhibited the same specific in vitro biological activity. These results revealed that the employed strategy had a positive effect on the cell specific productivity of CHO-K1-hGM-CSF cells without affecting product quality, representing a novel procedure for the rhGM-CSF production process.
引用
收藏
页码:17 / 21
页数:5
相关论文
共 22 条
  • [1] Andersen DC, 2000, BIOTECHNOL BIOENG, V70, P25, DOI 10.1002/1097-0290(20001005)70:1<25::AID-BIT4>3.0.CO
  • [2] 2-Q
  • [3] Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor
    Armitage, JO
    [J]. BLOOD, 1998, 92 (12) : 4491 - 4508
  • [4] RECOMBINANT HUMAN INTERFERON-GAMMA - DIFFERENCES IN GLYCOSYLATION AND PROTEOLYTIC PROCESSING LEAD TO HETEROGENEITY IN BATCH CULTURE
    CURLING, EMA
    HAYTER, PM
    BAINES, AJ
    BULL, AT
    GULL, K
    STRANGE, PG
    JENKINS, N
    [J]. BIOCHEMICAL JOURNAL, 1990, 272 (02) : 333 - 337
  • [5] Impact of temperature reduction and expression of yeast pyruvate carboxylase on hGM-CSF-producing CHO cells
    Fogolín, MB
    Wagner, R
    Etcheverrigaray, M
    Kratje, R
    [J]. JOURNAL OF BIOTECHNOLOGY, 2004, 109 (1-2) : 179 - 191
  • [6] N- and O-linked carbohydrates and glycosylation site occupancy in recombinant human granulocyte-macrophage colony-stimulating factor secreted by a Chinese hamster ovary cell line
    Forno, G
    Fogolin, MB
    Oggero, M
    Kratje, R
    Etcheverrigaray, M
    Conradt, HS
    Nimtz, M
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2004, 271 (05): : 907 - 919
  • [7] Enhancement of productivity of recombinant α-amidating enzyme by low temperature culture
    Furukawa, K
    Ohsuye, K
    [J]. CYTOTECHNOLOGY, 1999, 31 (1-2) : 85 - 94
  • [8] CHARACTERIZATION OF CHANGES IN THE GLYCOSYLATION PATTERN OF RECOMBINANT PROTEINS FROM BHK-21-CELLS DUE TO DIFFERENT CULTURE CONDITIONS
    GAWLITZEK, M
    VALLEY, U
    NIMTZ, M
    WAGNER, R
    CONRADT, HS
    [J]. JOURNAL OF BIOTECHNOLOGY, 1995, 42 (02) : 117 - 131
  • [9] Increased productivity of recombinant tissular plasminogen activator (t-PA) by butyrate and shift of temperature: a cell cycle phases analysis
    Hendrick, V
    Winnepenninckx, P
    Abdelkafi, C
    Vandeputte, O
    Cherlet, M
    Marique, T
    Renemann, G
    Loa, A
    Kretzmer, G
    Werenne, J
    [J]. CYTOTECHNOLOGY, 2001, 36 (1-3) : 71 - 83
  • [10] CLINICAL PHARMACOKINETIC STUDIES OF A HUMAN HEMATOPOIETIC GROWTH-FACTOR, GM-CSF
    HOVGAARD, D
    MORTENSEN, BT
    SCHIFTER, S
    NISSEN, NI
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1992, 22 (01) : 45 - 49